Literature DB >> 21404136

Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.

Keishi Makino1, Toshinori Hirai, Hideo Nakamura, Ryuji Murakami, Mika Kitajima, Yoshinori Shigematsu, Rumi Nakashima, Shinya Shiraishi, Hiroyuki Uetani, Koya Iwashita, Masuma Akter, Yasuyuki Yamashita, Jun-ichi Kuratsu.   

Abstract

OBJECTIVE: It is sometimes difficult to distinguish between primary central nervous system lymphomas (PCNSL) and glioblastoma multiforme (GBM). The aim of this study was to investigate whether the addition of (18)F-2-fluoro-2-deoxy-D: -glucose positron emission tomography ([(18)F]FDG-PET) and apparent diffusion coefficients (ADC) to conventional MRI improves diagnostic accuracy for distinguishing between PCNSL and GBM with similar MRI findings.
METHODS: We used conventional- and diffusion-weighted MRI and FDG-PET scans of 21 patients with histologically confirmed brain tumors exhibiting similar MRI findings (PCNSL, n = 14, GBM, n = 7) in our observer performance study that consisted of 3 interpretation sessions. ADC and maximum standard uptake values (SUV(max)) of the tumors were calculated. Three radiologists first interpreted conventional MRI (1st session), then they read images to which the ADC value had been added (2nd session), and finally they interpreted images supplemented with SUV(max) (3rd session). Observer performance was evaluated using κ statistic and receiver operating characteristics analyses.
RESULTS: The addition of ADC values to conventional MRI failed to improve the differentiation between PCNSL and GBM. The addition of SUV(max) at the third session improved the diagnostic accuracy of all 3 readers and resulted in higher interobserver agreement; mean accuracy was 95% (range 93-100%). In one observer the accuracy of tumor differentiation was significantly improved at the third compared to the second session (p = 0.017).
CONCLUSIONS: In a selected group of PCNSL and GBM with similar MRI findings, the addition of quantitative FDG-PET to MRI may improve their differentiation. ADC measurement did not allow further discrimination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21404136     DOI: 10.1007/s12149-011-0483-1

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  24 in total

1.  18F-FDG PET/CT in primary brain lymphoma.

Authors:  Domenico Albano; Giovanni Bosio; Mattia Bertoli; Raffaele Giubbini; Francesco Bertagna
Journal:  J Neurooncol       Date:  2017-11-17       Impact factor: 4.130

2.  Accuracy of apparent diffusion coefficients and enhancement ratios on magnetic resonance imaging in differentiating primary cerebral lymphomas from glioblastoma.

Authors:  Shayan Sirat Maheen Anwar; Mirza Zain Baig; Altaf Ali Laghari; Fatima Mubarak; Muhammad Shahzad Shamim; Umaima Ayesha Jilani; Muhammad Usman Khalid
Journal:  Neuroradiol J       Date:  2019-06-12

Review 3.  Brain tumors.

Authors:  Karl Herholz; Karl-Josef Langen; Christiaan Schiepers; James M Mountz
Journal:  Semin Nucl Med       Date:  2012-11       Impact factor: 4.446

4.  Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with 89Zr-Df-IAB2M anti-PSMA minibody.

Authors:  Masahide Matsuda; Eiichi Ishikawa; Tetsuya Yamamoto; Kentaro Hatano; Akira Joraku; Yuichi Iizumi; Yosuke Masuda; Hiroyuki Nishiyama; Akira Matsumura
Journal:  J Neurooncol       Date:  2018-03-09       Impact factor: 4.130

5.  SUV navigator enables rapid [18F]-FDG PET/CT image interpretation compared with 2D ROI and 3D VOI evaluations.

Authors:  Atsutaka Okizaki; Michihiro Nakayama; Shunta Ishitoya; Kaori Nakajima; Masaaki Yamashina; Tamio Aburano; Koji Takahashi
Journal:  Jpn J Radiol       Date:  2017-05-11       Impact factor: 2.374

6.  Usefulness of dual isotope 123I-IMP and 201Tl SPECT for the diagnosis of primary central nervous system lymphoma and glioblastoma.

Authors:  Sho Osawa; Masahiko Tosaka; Keishi Horiguchi; Azusa Tokue; Tetsuya Higuchi; Yoshito Tsushima; Yuhei Yoshimoto
Journal:  Int J Clin Oncol       Date:  2022-05-13       Impact factor: 3.850

7.  Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography.

Authors:  Koji Yamashita; Takashi Yoshiura; Akio Hiwatashi; Osamu Togao; Koji Yoshimoto; Satoshi O Suzuki; Koichiro Abe; Kazufumi Kikuchi; Yasuhiro Maruoka; Masahiro Mizoguchi; Toru Iwaki; Hiroshi Honda
Journal:  Neuroradiology       Date:  2012-09-09       Impact factor: 2.804

8.  Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma-a narrative review.

Authors:  Simone Krebs; Julia G Barasch; Robert J Young; Christian Grommes; Heiko Schöder
Journal:  Ann Lymphoma       Date:  2021-06-30

9.  Classification of cerebral lymphomas and glioblastomas featuring luminance distribution analysis.

Authors:  Toshihiko Yamasaki; Tsuhan Chen; Toshinori Hirai; Ryuji Murakami
Journal:  Comput Math Methods Med       Date:  2013-06-06       Impact factor: 2.238

10.  Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Authors:  Ramon F Barajas; Letterio S Politi; Nicoletta Anzalone; Heiko Schöder; Christopher P Fox; Jerrold L Boxerman; Timothy J Kaufmann; C Chad Quarles; Benjamin M Ellingson; Dorothee Auer; Ovidiu C Andronesi; Andres J M Ferreri; Maciej M Mrugala; Christian Grommes; Edward A Neuwelt; Prakash Ambady; James L Rubenstein; Gerald Illerhaus; Motoo Nagane; Tracy T Batchelor; Leland S Hu
Journal:  Neuro Oncol       Date:  2021-07-01       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.